MUMBAI, India, April 18 -- Intellectual Property India has published a patent application (202517028374 A) filed by Daiichi Sankyo Company, Limited, Tokyo, on March 26, for 'antibody-drug conjugate including mutant fc region.'
Inventor(s) include Hara Kyoko; Chihara Masataka; Shinozaki Naoya; Nagaoka Nobumi; Tsuda Masashi; and Kadohira Mariko.
The application for the patent was published on April 18, under issue no. 16/2025.
According to the abstract released by the Intellectual Property India: "[Problem] It is desired to develop a molecule that maintains antitumor activity and offers excellent safety. It is also desired to develop an antibody-drug conjugate that can be administered systemically and delivers a STING agonist specifically ...